Source Link
Excerpt:
Informed consent is a pillar of any ethical medical practice or treatment, but like the pseudo-science cited by proponents of “transgender” genital mutilation and chemical castration, it is notoriously absent from discussions about whether to pursue the irreversible medical interventions.
On Monday, the Federal Trade Commission (FTC) launched an inquiry, requesting public input, as to the true scope of information provided to would-be patients — with a particular focus on children — by doctors or other health professionals before being convinced to start the experimental and permanently harmful interventions.
The FTC says it wants to “better understand how consumers may have been exposed to false or unsupported claims about ‘gender-affirming care,’ especially as it relates to minors, and to gauge the harms consumers may be experiencing.”
The inquiry follows a July 9 event where the FTC heard from a variety doctors, detransitioners, parents, and medical ethicists on the subject of deceptive trade practices when it comes to fully describing the risks involved with the unproven and often gruesome medical procedures.
